To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Percutaneous Coronary Intervention

PROTECT II Trial

A Prospective, Multi-center, Randomized Controlled Trial of the Impella® Recover LP 2.5 System Versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non-Emergent High Risk PCI

Principal Investigator

David E. Leeman, MD

Co-Investigators

Donald E. Cutlip, MD
Duane S. Pinto, MD
Samuel J. Shubrooks, Jr., MD

Coordinator

Paula Rooney, RN
Phone: 617-632-7484
Email: prooney@bidmc.harvard.edu

Focus: Patients undergoing non-emergency, high-risk percutaneous coronary intervention (PCI)

The PROTECT II trial is assessing the safety and effectiveness of the FED-approved Impella® Recover LP 2.5 System compared to intra-aortic balloon pump (IABP) use in subjects undergoing non-emergent high-risk percutaneous coronary intervention (PCI).